These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6527354)

  • 1. A new method of iodine labelling of peptide hormones.
    Escher E
    J Recept Res; 1984; 4(1-6):331-6. PubMed ID: 6527354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stoichiometric labeling of peptides by iodination on tyrosyl or histidyl residues.
    Tsomides TJ; Eisen HN
    Anal Biochem; 1993 Apr; 210(1):129-35. PubMed ID: 8489008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of specific radioactivities in labelled hormones by self-displacement analysis.
    Calvo JC; Radicella JP; Charreau EH
    Biochem J; 1983 May; 212(2):259-64. PubMed ID: 6882371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments in techniques for radioiodination of peptide hormones and other proteins.
    Karonen SL
    Scand J Clin Lab Invest Suppl; 1990; 201():135-8. PubMed ID: 2244182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodination of mouse EGF with chloramine T at 4 degrees C: characterization of the iodinated peptide and comparison with other labelling methods.
    Wouters-Ballman P; Donnay I; Devleeschouwer N; Verstegen J
    J Recept Signal Transduct Res; 1995 Apr; 15(5):737-46. PubMed ID: 8747883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-131 labelled octreotide: not an option for somatostatin receptor therapy.
    Bakker WH; Breeman WA; van der Pluijm ME; de Jong M; Visser TJ; Krenning EP
    Eur J Nucl Med; 1996 Jul; 23(7):775-81. PubMed ID: 8662116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hydra head activator in human blood circulation. Degradation of the synthetic peptide by plasma angiotensin-converting enzyme.
    Roberge M; Escher E; Schaller HC; Bodenmüller H
    FEBS Lett; 1984 Aug; 173(2):307-13. PubMed ID: 6086405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of head activator (HA)-related peptides and development of HA-radioimmunoassay.
    Sakura N; Nishijima M; Uchida Y; Tani T; Hashimoto T
    Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2327-33. PubMed ID: 3664830
    [No Abstract]   [Full Text] [Related]  

  • 9. Iodinated derivatives of vasoactive intestinal peptide (VIP), PHI and PHM: purification, chemical characterization and biological activity.
    McMaster D; Suzuki Y; Rorstad O; Lederis K
    Peptides; 1987; 8(4):663-76. PubMed ID: 3628082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enzymatic solid-phase method for trace iodination of proteins and peptides with 125-iodine.
    Karonen SL; Mörsky P; Siren M; Seuderling U
    Anal Biochem; 1975 Jul; 67(1):1-10. PubMed ID: 1170772
    [No Abstract]   [Full Text] [Related]  

  • 11. The suitability of iodinated Angiotensin-(1-7) peptides as pharmacological tools.
    Loot AE; van Buiten A; Roks AJ; Henning RH
    J Pharmacol Toxicol Methods; 2005; 51(1):51-5. PubMed ID: 15596114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simplified procedure for the labelling of thyroid hormones.
    Patel MC; Desai KB; Mehta MN; Glenn HJ
    Int J Appl Radiat Isot; 1974 Sep; 25(9):421-2. PubMed ID: 4422197
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparation and immunoreactive properties of monoiodinated angiotensin labelled at high specific activity.
    Gandolfi C; Malvano R; Rosa U
    Biochim Biophys Acta; 1971 Nov; 251(2):254-61. PubMed ID: 11452391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiolabeling (125I) with high specific activity of the 1-34 N-terminal derivative of bovine parathormone without loss of biological activity].
    Cloix JF; Bader CA; Monet JD; Funck-Brentano JL
    Pathol Biol (Paris); 1975 Dec; 23(10):827-31. PubMed ID: 772527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeling of antigens: procedures and assessment of properties.
    Chervu LR; Murty DR
    Semin Nucl Med; 1975 Apr; 5(2):157-72. PubMed ID: 1121670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of 125I-labeled [2-8]-leucopyrokinin, active analog of leucopyrokinin in rats.
    Plech A; Rykaczewska-Czerwińska M; Ryszka F; Suszka-Switek A; Dolińska B; Konopińska D
    Acta Pol Pharm; 2005; 62(5):393-7. PubMed ID: 16459488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Labeling of beta-endorphin and beta-lipotropin with iodine 125].
    Deby-Dupont G; Reuter AM; Joris J; Vrindts-Gevaert Y; Franchimont P
    C R Seances Soc Biol Fil; 1983; 177(2):259-68. PubMed ID: 6309339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison and evaluation of different methods for alpha-MSH labelling.
    Ghanem G; Legros F; Lejeune F; Frühling J
    J Immunol Methods; 1982 Oct; 54(2):223-32. PubMed ID: 6757323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromine-77 and iodine-123 radiopharmaceuticals.
    Stöcklin G
    Int J Appl Radiat Isot; 1977; 28(1-2):131-47. PubMed ID: 323157
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation of mono- and di-iodine 125 tyramines for conjugation labelling.
    Kakabakos SE; Livaniou E; Evangelatos SA; Evangelatos GP; Ithakissios DS
    Eur J Nucl Med; 1991; 18(12):952-4. PubMed ID: 1778205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.